State
73,809 recalls have nationwide distribution and so reach New Mexico. 3,638 additional recalls listed New Mexico specifically in their distribution scope.
Of the 3,638 recalls naming New Mexico we have scored against our rubric, 745 (20%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 816 (22%) are Severe.
Which agencies issued them
These figures cover only the 3,638 recalls whose distribution notice names New Mexico specifically. The 73,809 nationwide recalls listed below reach every state, so counting them here would make every state page show the same numbers.
General Motors is recalling 2016-2018 Chevrolet Silverado 3500 and GMC Sierra 3500 trucks because a fuel sensor defect may cause the front tank to overfill, potentially leading to a fuel leak and fire.
Daimler Trucks is recalling 2018-2020 Freightliner Cascadia trucks because the driver's frontal air bag may deploy unexpectedly, increasing crash risk.
Delta Electronics is recalling Eltek THEIA HE-t solar inverters because failing capacitors can cause heat buildup and cover ejection, posing fire and impact risks.
KTM is recalling 2015-2016 1290 Super Adventure motorcycles because fuel may leak from the tank cover, increasing fire risk.
General Motors is recalling specific 2016-2018 Cadillac and Chevrolet vehicles because the electric power steering system may fail, increasing crash risk.
Prinston Pharmaceutical Inc. is recalling Irbesartan and Hydrochlorothiazide tablets because FDA testing found the impurity NDEA above acceptable limits.
Prinston Pharmaceutical Inc. is recalling Irbesartan and Hydrochlorothiazide tablets because FDA testing found the impurity N-nitrosodimethylamine (NDEA) above acceptable levels.
Prinston Pharmaceutical Inc is recalling Irbesartan and Hydrochlorothiazide tablets because FDA labs found the impurity NDEA above acceptable levels.
Prinston Pharmaceutical Inc. is recalling Irbesartan and Hydrochlorothiazide tablets because FDA testing found N-nitrosodimethylamine (NDEA) above the acceptable daily intake level.
Aisin World Corp. of America is recalling Transmission Control Modules for 2016-2019 Mazda Miata MX-5 and 2017-2019 Fiat 124 vehicles. Incorrect programming may cause unexpected downshifting and abrupt deceleration.
Prinston Pharmaceutical Inc. is recalling Irbesartan 300 mg tablets because FDA testing found N-nitrosodimethylamine (NDEA) levels above the interim acceptable daily intake.
Subaru is recalling 2019 Forester and Crosstrek vehicles because a steering connector may short circuit, causing a loss of power steering assistance.
Roche Diagnostics is recalling Anti-HAV IgM test systems due to potential erroneous result messages on the cobas e 602 module.
Medtronic is recalling 1,100 Reservoir Y Adapters because the Y-connectors may tear or crack, potentially causing blood loss and circuit breaches during autotransfusion.
Sun Pharmaceutical is recalling BromSite (bromfenac) 0.075% ophthalmic solution due to a lack of sterility assurance. The recall affects 69,840 bottles distributed nationwide.
Haemonetics is recalling 4,576 Cell Saver Elite Processing Kits because the 70ml centrifuge bowl may leak during cell salvage processing.
Medtronic is recalling 7,587 Suction and Anticoagulation Assemblies because Y-connectors may tear or crack, potentially causing leaks and blood loss.
Siemens Healthcare Diagnostics is recalling 217 Atellica IM 1300 Analyzers worldwide due to multiple issues identified in software version 1.14.2 and lower.
Siemens Healthcare Diagnostics is recalling Atellica analyzer software versions 1.14.2 and lower due to multiple identified issues affecting in vitro diagnostic testing.
Dell is recalling hybrid power adapters sold with power banks because the casing can break, exposing internal metal components and posing an electric shock hazard.
Haemonetics is recalling 11,208 units of Cell Saver 5/5+ Bowl Sets because the 70ml centrifuge bowls may leak during cell salvage processing.
Siemens Healthcare Diagnostics is recalling Atellica analyzer software versions 1.14.2 and lower due to multiple identified issues affecting in vitro diagnostic testing systems.
Mylan Pharmaceuticals is recalling specific lots of Fexofenadine HCl 180 mg tablets because routine stability testing showed slightly elevated related compounds.
Akorn, Inc. is recalling specific lots of Gentamicin Sulfate Ophthalmic Solution because crystalline particles were detected during clarity testing.
Siemens Healthcare Diagnostics is recalling 410 Atellica Sample Handler Prime units because software version 1.14.2 and lower contain multiple issues.